SCHEMBL863827

SCHEMBL863827

O=C1CCCC(CO)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5155772 1.00
SCHEMBL5156795 1.00
SCHEMBL22166739 0.94 CYP1A2 (0.38)
SCHEMBL283689 0.86
SCHEMBL167570 0.86
SCHEMBL931042 0.86
SCHEMBL13449809 0.85 CYP1A2 (0.46)
SCHEMBL12459735 0.85 CYP1A2 (0.46)
SCHEMBL864534 0.82 CYP1A2 (0.51)
SCHEMBL864228 0.80 CYP1A2 (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3109246-B1 THIOPYRANOSE COMPOUND AND METHOD FOR PRODUCING SAME FUJIFILM CORP (JP) 2021-11-03 EP disclosed
US-9815812-B2 Thiopyranose compound and method for producing same FUJIFILM CORPORATION (JP) 2017-11-14 US disclosed
US-9815812-B2 Thiopyranose compound and method for producing same FUJIFILM CORPORATION (JP) 2017-11-14 US disclosed
EP-3109246-A1 THIOPYRANOSE COMPOUND AND METHOD FOR PRODUCING SAME Fujifilm Corporation (JP) 2016-12-28 EP disclosed
US-20160355497-A1 THIOPYRANOSE COMPOUND AND METHOD FOR PRODUCING SAME FUJIFILM CORPORATION (JP) 2016-12-08 US disclosed
US-20160355497-A1 THIOPYRANOSE COMPOUND AND METHOD FOR PRODUCING SAME FUJIFILM CORPORATION (JP) 2016-12-08 US disclosed
US-20120077126-A1 Fluorine-Containing Compound, Fluorine-Containing Polymer Compound, Resist Composition, Top Coat Composition And Pattern Formation Method CENTRAL GLASS COMPANY, LIMITED (JP) 2012-03-29 US disclosed
EP-2134696-A2 PROCESSES FOR THE PREPARATION OF STATINS, PARTICULARLY ROSUVASTATIN, AND INTERMEDIATES FOR THE PREPARATION THEREOF Lek Pharmaceuticals D.D. (SI) 2009-12-23 EP disclosed
WO-2008119810-A2 PROCESSES FOR THE PREPARATION OF STATINS, PARTICULARLY ROSUVASTATIN, AND INTERMEDIATES FOR THE PREPARATION THEREOF LEK PHARMACEUTICALS D.D. (SI) 2008-10-09 WO disclosed
EP-1740522-A2 BISPHENYL COMPOUNDS USEFUL AS VITAMIN D SB 3 /SB RECEPTOR AGONISTS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2007-01-10 EP disclosed
US-7038064-B2 Process for producing hydroxylactones DIACEL CHEMICAL INDUSTRIES, LTD. (JP) 2006-05-02 US disclosed
US-20060025474-A1 Bisphenyl compounds useful as vitamin D3 receptor agonists CHUGAI SEIYAKU KABUSHIKA KAISHA (JP) 2006-02-02 US disclosed
WO-2005087700-A2 BISPHENYL COMPOUNDS USEFUL AS VITAMIN D3 RECEPTOR AGONISTS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-09-22 WO disclosed
EP-1302469-B1 PROCESS FOR PRODUCING HYDROXYLACTONE DAICEL CHEM (JP) 2005-03-30 EP disclosed
US-20040024228-A1 Process for producing hydroxylactones DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2004-02-05 US disclosed
EP-1302469-A1 PROCESS FOR PRODUCING HYDROXYLACTONE Daicel Chemical Industries, Ltd. (JP) 2003-04-16 EP disclosed